This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
has gotten investors even more bullish about the stock and its long-term prospects. It has been reducing the scale of its operations to become leaner, while also focusing on the medicinal market -- which would likely be legalizedbefore the recreational market. Legalization in the U.S. million Canadian dollars.
One thing you should know off the bat is that marijuana legalization isn't inevitable in the U.S., Unlike Tilray's Irwin Simon and Canopy's David Klein, who are often on investing shows talking up their growth prospects, odds are you probably haven't even seen Bachtell or heard of him. They're also burning through tons of cash.
This is why many cannabis companies focus on their adjusted earningsbeforeinterest, taxes, depreciation, and amortization ( EBITDA ) numbers. There are some encouraging opportunities, such as in Germany, where the country recently legalized cannabis for personal use. million Canadian dollars ($1.4 once they open up.
It recently added more fuel to its growth engine by making a $2 billion acquisition that will supply it with incremental cash flow while enhancing its growth prospects. The company is paying about 10 times estimated 2024 earningsbeforeinterest, taxes, depreciation, and amortization ( EBITDA ) for these assets.
Aurora reported an adjusted earningsbeforeinterest, taxes, depreciation, and amortization ( EBITDA ) profit of CA$3.4 But with cannabis investors losing heavily on pot stocks in recent years and no progress on marijuana legalization in the U.S., legalization efforts. million last quarter. the optimism has faded.
It also reported a record adjusted earningsbeforeinterests, taxes, depreciation, and amortization ( EBITDA ) of CA$3.4 Aurora's prospects are uncertain One of the reasons behind Aurora Cannabis's poor results in recent years is that the recreational cannabis market in Canada has been a mess. Its revenue of 63.4
The interest has always been there. Several more states have legalized mobile gambling, and sports betting in particular. While it still provides a variety of fantasy sports offerings, it also operates a conventional sportsbook where legally allowed. are interested in sports-based wagers. Not a lot, actually.
DraftKings is gaining access to new markets as more governments move to legalize betting on sports. With the prospect of higher tax revenue likely to eventually lure the remaining state legislatures to legalize sports gambling, DraftKings has plenty of room for further expansion within the United States.
Particularly encouraging are the consecutive quarters of positive adjusted earningsbeforeinterest, taxes, depreciation, and amortization ( EBITDA ) , reaching $194 million in Q2. The implications of this legal battle could disrupt Coinbase's business model significantly.
Tilray now sees adjusted earningsbeforeinterest, taxes, depreciaition, and amortization ( EBITDA ) of $60 million to $63 million (versus previous guidance for $68 million to $78 million), and management no longer expects to achieve positive free cash flow this year as previously anticipated.
legal cannabis market at $28.9 That's good news for prospective investors, though, as the dividend yield has risen past 9%. Innovative showed its strength in its second-quarter earnings, which it reported on Aug. Cannabis legalization is sweeping over North America – 19 states plus Washington, D.C., billion by 2026.
Cresco Labs Cannabis stocks have somewhat fallen out of favor lately over concerns about the lack of progress toward federal legalization in the U.S., but some still have enormous long-term potential even if legalization never comes. One factor that pressured revenue was a 5.6%
The company has achieved positive adjusted earningsbeforeinterest, taxes, depreciation and amortization ( EBITDA ) for three straight quarters. Aurora's focus, however, remains predominantly on the medical marijuana market, where growth prospects aren't nearly as promising as in the recreational market.
Both have grabbed plenty of headlines in recent years, both have failed to keep pace with the market in 2023, and neither seems to have strong prospects. Aurora Cannabis Aurora Cannabis has consistently been one of the most talked-about stocks in the Canadian pot market since recreational adult use became legal some five years ago.
It has been almost five years since Canada first legalized marijuana for recreational use. On Monday the stock closed at $0.863, as it faces the prospect of another reverse stock split in its future. Unfortunately, to say that things haven't gone well for Aurora -- or many other Canadian producers -- would be a huge understatement.
Very few public companies offer monthly dividends, and the ones that do are typically real estate investment trusts (REITs) because they are legally required to pay out 90% of their taxable earnings to shareholders. Prospects look promising for LTC Properties because America's aging population should keep demand for its services high.
And there has been some reform happening in Germany of late, which has Tilray bullish on both its near and long-term growth prospects in that market. It won't legalize marijuana for recreational use, but it will result in cannabis no longer being a prohibited substance, making it easier for doctors to prescribe it for medicinal purposes.
Using EBITDA Multiples to Understand Your Valuation EBITDA represents your earningsbeforeinterest, taxes, depreciation, and amortization. This metric offers potential buyers a clear snapshot of your businesss core profitability, free from the effects of taxes, financing, and non-operational factors.
Understanding how prospective buyers determine your business’s value is a key factor in a successful sale. Let’s start by defining the terms: Your EBITDA is your earningsbeforeinterest, taxes, depreciation, and amortization.
Senate, and President Biden has done little to advance the legalization of marijuana in the world's most lucrative market for weed. Canada legalizing recreational weed for sale in October 2018 was expected to be a watershed moment for licensed producers. Unfortunately, meaningful reforms have continually fallen flat in the U.S.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content